perifosine has been researched along with u 0126 in 1 studies
Studies (perifosine) | Trials (perifosine) | Recent Studies (post-2010) (perifosine) | Studies (u 0126) | Trials (u 0126) | Recent Studies (post-2010) (u 0126) |
---|---|---|---|---|---|
245 | 31 | 140 | 2,816 | 2 | 1,213 |
Protein | Taxonomy | perifosine (IC50) | u 0126 (IC50) |
---|---|---|---|
RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | 0.29 | |
Serine/threonine-protein kinase B-raf | Homo sapiens (human) | 0.25 | |
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.07 | |
Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | 0.2816 | |
Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | 0.2529 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cartagena-Rivera, AX; Chadwick, RS; Logue, JS | 1 |
1 other study(ies) available for perifosine and u 0126
Article | Year |
---|---|
c-Src activity is differentially required by cancer cell motility modes.
Topics: Actins; Amino Acid Substitution; Butadienes; Cell Adhesion; Cell Movement; Dasatinib; Humans; Imidazoles; Mutant Proteins; Neoplasms; Nitriles; Phosphorylcholine; Protein Kinase Inhibitors; Proto-Oncogene Proteins pp60(c-src); Quinolines; Tumor Cells, Cultured | 2018 |